Key facts
- This page summarizes Eric Dobmeier's Form 4 filing for Jade Biosciences, Inc. (JBIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 May 2025, 18:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer.